The "Apoptosis - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Apoptosis is estimated at US$5.4 Billion in 2023 and is projected ...
The global synthetic biology market growth forecasted to transform from USD 12.33 billion in 2024 to USD 31.52 billion in 2029, driven by a CAGR of 20.6%. Rising demand for bio-based products, growing ...
ToolGen, a leading gene editing company, and PlantArcBio , a leading ag-biotech company specializing in gene discovery and biological components to enhance agricultural crop traits, announced today a ...
The gene-editing technique known as CRISPR is promising to revolutionize medicine. Some researchers are trying to help make it available for people with very rare genetic disorders.
The inducement grant consisted of time-based restricted stock units (“RSUs”) for 3,521 shares of Intellia’s common stock, with one-third of such RSUs vesting on December 1, 2025, 2026, and 2027.